Black Diamond Therapeutics, Inc. (BDTX) insider trading
Over the last 12 months, 0 insiders bought $0 and 0 insiders sold $0 of Black Diamond Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Mar 19, 2025: Biotech Growth N V sold 5,784,292 shares ($12.0M)